Abstract:Background The most common type of kidney cancer that easily metastasizes is clear cell renal cell carcinoma (ccRCC). The expression levels of hyaluronan-mediated motility receptor (HMMR) in many tumor types are significantly enhanced. HMMR is closely associated with tumor-related progression, treatment resistance, and discouraging prognosis, has yet to be fully investigated in terms of its expression patterns and molecular mechanisms of action in ccRCC. Further research is imperative to elucidate these aspects. Methods We used The Cancer Genome Atlas (TCGA) database to preliminarily investigate HMMR expression and function in ccRCC. We assessed the differential expression level of HMMR between ccRCC cancerous tissues and their matched non-tumor tissues. Subsequently, a series of in vivo and in vitro experiments were designed to elucidate the biological function of HMMR in ccRCC, including Transwell migration assays, CCK-8 assays, clone formation assays and subcutaneous xenograft experiments in nude mice. Through bioinformatics analysis, we identified potential microRNAs (miRNAs) that may regulate HMMR, as well as the possible signaling pathways involved. Finally, we conducted a series of cellular functional experiments to validate our hypotheses regarding the HMMR axis. Results HMMR expression was observably up-regulated in tumor tissues of ccRCC patients, and elevated HMMR expression level showed a strong correlation with ccRCC progression and adverse prognoses of patients. Knocking down HMMR inhibited the proliferative and migratory abilities of ccRCC cells, while its overexpression amplified these oncogenic properties. In nude mouse model, reduced HMMR expression inhibited ccRCC tumor proliferation in vivo. Furthermore, overexpression of an upstream transcriptional regulator, miR-9-5p, effectively downregulated HMMR expression and thus impeded ccRCC cells proliferation and migration. In addition, HMMR might influence ccRCC growth via the Epithelial-Mesenchymal Transition (EMT) pathway and the Janus Kinase1/Signal Transducer and Activator of Transcription1 (JAK1/STAT1) pathway. Conclusions HMMR is overexpressed in ccRCC, and there is a significant link between high HMMR expression and tumor progression, as well as poor patient prognosis. Specifically, HMMR could be targeted and inhibited by miR-9-5p and might modulate the tumorigenesis and progression of ccRCC through both EMT and JAK1/STAT1 signaling pathway.

Musashi1 Promotes Tumor Metastasis and is a Prognostic Marker for Renal Carcinoma

196P Expression of Musashi-1 Protein and Its Implications in Progression and Prognosis of Gastric Cancer

Matrix metalloproteinase-1 expression in breast carcinoma: a marker for unfavorable prognosis.

Inhibition of RNA-Binding Protein Musashi-1 Suppresses Malignant Properties and Reverses Paclitaxel Resistance in Ovarian Carcinoma

Mir-9-5p/hmmr Regulates the Tumorigenesis and Progression of Clear Cell Renal Cell Carcinoma Through EMT and JAK1/STAT1 Signaling Pathway

Musashi-1 Enhances Glioblastoma Cell Migration and Cytoskeletal Dynamics through Translational Inhibition of Tensin3

Msi-1 is a Predictor of Survival and a Novel Therapeutic Target in Colon Cancer

Musashi2 as a novel predictive biomarker for liver metastasis and poor prognosis in colorectal cancer.

Msi1 Promotes Tumor Progression by Epithelial-to-mesenchymal Transition in Cervical Cancer.

Msi1 promotes breast cancer metastasis by regulating invadopodia-mediated extracellular matrix degradation via the Timp3–Mmp9 pathway

TMSB10 Promotes Migration and Invasion of Cancer Cells and is a Novel Prognostic Marker for Renal Cell Carcinoma.

[Musashi-1 Positively Regulates Growth and Proliferation of Hepatoma Cells in Vitro].

Increased Musashi 2 Expression Indicates a Poor Prognosis and Promotes Malignant Phenotypes in Gastric Cancer

Musashi2 promotes the proliferation and migration of colorectal cancer by down-regulating Numb protein

Elevated MTA1 induced the migration and invasion of renal cell carcinoma through the NF-κB pathway

Msi1 Promotes Tumor Growth and Cell Proliferation by Targeting Cell Cycle Checkpoint Proteins P21, P27 and P53 in Cervical Carcinomas

MSI2 Knockdown Represses Extrahepatic Cholangiocarcinoma Growth and Invasion by Inhibiting Epithelial-Mesenchymal Transition.

Increased Expression of Metastasis-Associated in Colon Cancer-1 in Renal Cell Carcinoma is Associated with Poor Prognosis.

Musashi-2 is a Prognostic Marker for the Survival of Patients with Cervical Cancer.

The oncogene Musashi1 encodes novel miRNAs in breast cancer

<i>MC1R</i> Is a Prognostic Marker and Its Expression Is Correlated with MSI in Colorectal Cancer